|
|
Other links at Articles > Hematology-Oncology |
| 5. |
Adjuvant TKI Benefit in NSCLC Not So Clear Cut
|
|
|
Dr. West argues that the finding of a benefit with perioperative TKI therapy in patients with early-stage NSCLC does not justify expanding this therapy beyond clinical trials. Medscape Hematology-Oncology
|
|
|